Expression and Clinical Significance of Antiapoptotic Gene (Survivin) in NB4 and Acute Promyelocytic Leukemia Cells

Table 1

The results of survivin mRNA expression in de novo, relapse, and remission APL.

Group	𝑁	survivin-mRNA expression
		positive	𝑃 value
(1) de novo and relapse*	36	24 (67%)
L type (+)^#	28	19 (68%)
S type (+)	8	5 (63%)
(2) remission^&	22	8 (36%)
(3) acute leukemia	23	21 (91%)

Compared by remission ^∗𝑥²=5.07, 𝑃=0.024; ^#𝑥²=4.92,𝑃=0.027; compared by acute leukemia ^∗𝑥²=4.71,𝑃=0.03; ^&𝑥²=14.81,𝑃=0.00.